With the NB.1.8.1 "Nimbus" and XFG.* "Stratus" variants carving up dominance around the globe, it is time to ponder which variant might drive the next wave.
The leading contenders at this point are PY.1.1.1 and XFV.
#COVID19 #PY_1_1_1 #XFV
🧵
PY.1.1.1 is descended from "FLiRT" variant LF.7.9.1. PY.1.1 added the K679R mutation, then PY.1.1.1 added A435S (same mutation that characterised NB.1.8.1).
PY.1.1.1 is presumed to have originated from India, rising sharply to 14% frequency there in June.
🧵
PY.1.1.1 has also shown signs of growth in several other countries, notably rising to 3% in Canada and the US.
🧵
Here’s the latest detailed variant picture for India. While there were robust data volumes shared during May and early June, those dwindled to a trickle and have not been updated since late June.
It looks like PY.1.1.1 was on a trajectory to become dominant at that point.
🧵
Here are the International Traveller samples of PY.1.1.1. India has been the most commonly-reported country of origin.
This dataset (mostly arrivals in the US and Japan) is arguably more random, as it is not skewed by sequencing volumes.
🧵
Here's an animated map showing the spread of the PY.1.1.1 variant. The first samples were reported simultaneously from Manipur, India and New South Wales, Australia in late May
It was soon reported across Asia, North America and Europe and then spread rapidly around the globe
🧵
It has been particularly successful in India.
Locations are approximate - typically country and state/province.
🧵
I will start with PY.1.1.1 as my leading contender, based on it’s broader geographical distribution, including many countries with low and/or patchy data volumes.
🧵
Also there have been 11 samples of PY.1.1.1 reported in the International Traveller samples – the most representative sample set with a global perspective. There has been no XFV detected in that set, after several months.
I will continue to monitor this topic.
🧵
The usual caveats apply - recent sample sizes are smaller which might skew these results, and “global” sequencing data is dominated by wealthy countries, with many under-sampled regions.
🧵
Huge thanks to all the dedicated variant hunters who persevere with their crucial work away from the limelight, especially to Federico Gueli for his tips on new lineages, eg
Here’s the July 2025 update I just sent to my GitHub Sponsors.
I continued to share results from these projects, here and on other social media platforms
🧵
If you are in a position to support my open-source project work, then any amount is welcome. You just need to create a free GitHub account, and you can remain anonymous if you prefer.
There’s info on that page about how your contribution will be used.
This perspective excludes all the high-volume countries and regions that I routinely report on: Australia, NZ, Europe, Canada and the US. The remaining countries are aggregated into this report.
🧵
Here are the leading countries reporting the NB.1.8.1 "Nimbus" variant.
🧵
Here's the latest variant picture for the United States, to early July.
The XFG.* "Stratus" variant continued it’s dominance, growing to 58% frequency.
NB.1.8.1 "Nimbus" was fairly flat, finishing at 14%.
#COVID19 #USA #XFG #Stratus #NB_1_8_1 #Nimbus
🧵
Here are the leading US states reporting XFG.* "Stratus". New York state reported strong growth to 78%.
🧵
Here are the leading US states reporting NB.1.8.1 "Nimbus". Besides the International Traveller samples, it has been most common in California and Colorado, although all are roughly flat or declining lately.
🧵
The volatility is due to the ragged timing of submissions from various countries.
This perspective excludes all the high-volume countries and regions that I routinely report on: Australia, NZ, Europe, Canada and the US. The remaining countries are aggregated into this report.
🧵
Here are the leading countries reporting the NB.1.8.1 "Nimbus" variant.
🧵
Here's the latest variant picture for the United States, to late June.
The XFG.* "Stratus" variant grew to dominant at 40%, with LP.8.1.* at 28%.
Growth of the NB.1.8.1 "Nimbus" variant is slower, at 16%.
#COVID19 #USA #XFG #Stratus #NB_1_8_1 #Nimbus
🧵
For the US, the XFG.* "Stratus" variant shows a strong growth advantage of 5% per day (35% per week) over LP.8.1.*, with a crossover in mid-June.
🧵
Here are the leading US states reporting XFG.* "Stratus". New York state leads at 59%. It has also been quite common among the International Traveller samples at 46%.
🧵
Here are the trends across all the International Traveller samples. From that perspective, XFG.* "Stratus" is dominant at 48%.
This dataset (mostly arrivals in the US and Japan) is arguably more random, as it is not skewed by sequencing volumes.
🧵
Globally, the NB.1.8.1 "Nimbus" variant is showing a steady growth advantage of 3.1% per day (22% per week) over the LP.8.1.* variant, with a crossover in late May.
🧵